Cargando…

Transcriptome Analysis in Vulvar Squamous Cell Cancer

SIMPLE SUMMARY: The number of women, especially younger women, diagnosed with vulvar cancer, has been rising mainly due to the infection with human papilloma virus (HPV) over the last years. In contrast to other tumor entities, limited information on the underlying genetic changes is available, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieske, Katharina, Alawi, Malik, Jaeger, Anna, Wankner, Maximilian Christian, Eylmann, Kathrin, Reuter, Susanne, Lebok, Patrick, Burandt, Eike, Blessin, Niclas C., Schmalfeldt, Barbara, Oliveira-Ferrer, Leticia, Joosse, Simon A., Woelber, Linn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699756/
https://www.ncbi.nlm.nih.gov/pubmed/34944992
http://dx.doi.org/10.3390/cancers13246372
_version_ 1784620590385070080
author Prieske, Katharina
Alawi, Malik
Jaeger, Anna
Wankner, Maximilian Christian
Eylmann, Kathrin
Reuter, Susanne
Lebok, Patrick
Burandt, Eike
Blessin, Niclas C.
Schmalfeldt, Barbara
Oliveira-Ferrer, Leticia
Joosse, Simon A.
Woelber, Linn
author_facet Prieske, Katharina
Alawi, Malik
Jaeger, Anna
Wankner, Maximilian Christian
Eylmann, Kathrin
Reuter, Susanne
Lebok, Patrick
Burandt, Eike
Blessin, Niclas C.
Schmalfeldt, Barbara
Oliveira-Ferrer, Leticia
Joosse, Simon A.
Woelber, Linn
author_sort Prieske, Katharina
collection PubMed
description SIMPLE SUMMARY: The number of women, especially younger women, diagnosed with vulvar cancer, has been rising mainly due to the infection with human papilloma virus (HPV) over the last years. In contrast to other tumor entities, limited information on the underlying genetic changes is available, and thus treatment advances, especially the development of personalized treatments, are hampered. We aimed to explore the RNA expression profiles in a group of 24 vulvar cancer samples in order to detect potential prognostic markers and therapeutic targets in order to establish to a more profound understanding of vulvar cancer carcinogenesis. ABSTRACT: To date, therapeutic strategies in vulvar squamous cell carcinoma (VSCC) are lacking molecular pathological information and targeted therapy hasn’t been approved in the treatment of VSCC, yet. Two etiological pathways are widely accepted: HPV induced vs. HPV independent, associated with chronic skin disease, often harboring TP53 mutations (mut). The aim of this analysis was to analyze the RNA expression patterns for subtype stratification on VSCC samples that can be integrated into the previously performed whole exome sequencing data for the detection of prognostic markers and potential therapeutic targets. We performed multiplex gene expression analysis (NanoString) with 770 genes in 24 prior next generation sequenced samples. An integrative data analysis was performed. Here, 98 genes were differentially expressed in TP53mut vs. HPV+ VSCC, in the TP53mut cohort, where 56 genes were upregulated and 42 were downregulated in comparison to the HPV+ tumors. Aberrant expression was primarily observed in cell cycle regulation, especially in HPV+ disease. Within the TP53mut group, a distinct cluster was identified that was correlated to a significantly worse overall survival (p = 0.017). The RNA expression profiles showed distinct patterns with regard to the known VSCC subtypes and could potentially enable further subclassification in the TP53mut groups
format Online
Article
Text
id pubmed-8699756
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86997562021-12-24 Transcriptome Analysis in Vulvar Squamous Cell Cancer Prieske, Katharina Alawi, Malik Jaeger, Anna Wankner, Maximilian Christian Eylmann, Kathrin Reuter, Susanne Lebok, Patrick Burandt, Eike Blessin, Niclas C. Schmalfeldt, Barbara Oliveira-Ferrer, Leticia Joosse, Simon A. Woelber, Linn Cancers (Basel) Article SIMPLE SUMMARY: The number of women, especially younger women, diagnosed with vulvar cancer, has been rising mainly due to the infection with human papilloma virus (HPV) over the last years. In contrast to other tumor entities, limited information on the underlying genetic changes is available, and thus treatment advances, especially the development of personalized treatments, are hampered. We aimed to explore the RNA expression profiles in a group of 24 vulvar cancer samples in order to detect potential prognostic markers and therapeutic targets in order to establish to a more profound understanding of vulvar cancer carcinogenesis. ABSTRACT: To date, therapeutic strategies in vulvar squamous cell carcinoma (VSCC) are lacking molecular pathological information and targeted therapy hasn’t been approved in the treatment of VSCC, yet. Two etiological pathways are widely accepted: HPV induced vs. HPV independent, associated with chronic skin disease, often harboring TP53 mutations (mut). The aim of this analysis was to analyze the RNA expression patterns for subtype stratification on VSCC samples that can be integrated into the previously performed whole exome sequencing data for the detection of prognostic markers and potential therapeutic targets. We performed multiplex gene expression analysis (NanoString) with 770 genes in 24 prior next generation sequenced samples. An integrative data analysis was performed. Here, 98 genes were differentially expressed in TP53mut vs. HPV+ VSCC, in the TP53mut cohort, where 56 genes were upregulated and 42 were downregulated in comparison to the HPV+ tumors. Aberrant expression was primarily observed in cell cycle regulation, especially in HPV+ disease. Within the TP53mut group, a distinct cluster was identified that was correlated to a significantly worse overall survival (p = 0.017). The RNA expression profiles showed distinct patterns with regard to the known VSCC subtypes and could potentially enable further subclassification in the TP53mut groups MDPI 2021-12-19 /pmc/articles/PMC8699756/ /pubmed/34944992 http://dx.doi.org/10.3390/cancers13246372 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Prieske, Katharina
Alawi, Malik
Jaeger, Anna
Wankner, Maximilian Christian
Eylmann, Kathrin
Reuter, Susanne
Lebok, Patrick
Burandt, Eike
Blessin, Niclas C.
Schmalfeldt, Barbara
Oliveira-Ferrer, Leticia
Joosse, Simon A.
Woelber, Linn
Transcriptome Analysis in Vulvar Squamous Cell Cancer
title Transcriptome Analysis in Vulvar Squamous Cell Cancer
title_full Transcriptome Analysis in Vulvar Squamous Cell Cancer
title_fullStr Transcriptome Analysis in Vulvar Squamous Cell Cancer
title_full_unstemmed Transcriptome Analysis in Vulvar Squamous Cell Cancer
title_short Transcriptome Analysis in Vulvar Squamous Cell Cancer
title_sort transcriptome analysis in vulvar squamous cell cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699756/
https://www.ncbi.nlm.nih.gov/pubmed/34944992
http://dx.doi.org/10.3390/cancers13246372
work_keys_str_mv AT prieskekatharina transcriptomeanalysisinvulvarsquamouscellcancer
AT alawimalik transcriptomeanalysisinvulvarsquamouscellcancer
AT jaegeranna transcriptomeanalysisinvulvarsquamouscellcancer
AT wanknermaximilianchristian transcriptomeanalysisinvulvarsquamouscellcancer
AT eylmannkathrin transcriptomeanalysisinvulvarsquamouscellcancer
AT reutersusanne transcriptomeanalysisinvulvarsquamouscellcancer
AT lebokpatrick transcriptomeanalysisinvulvarsquamouscellcancer
AT burandteike transcriptomeanalysisinvulvarsquamouscellcancer
AT blessinniclasc transcriptomeanalysisinvulvarsquamouscellcancer
AT schmalfeldtbarbara transcriptomeanalysisinvulvarsquamouscellcancer
AT oliveiraferrerleticia transcriptomeanalysisinvulvarsquamouscellcancer
AT joossesimona transcriptomeanalysisinvulvarsquamouscellcancer
AT woelberlinn transcriptomeanalysisinvulvarsquamouscellcancer